CTLA4 and ovarian serous adenocarcinoma: Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity Before Anti-CTLA-4 Therapy Against High-Grade Serous Ovarian Cancer (43).